Question 1

What is the catalog number for CALML4, CT (CALML4, Calmodulin-like protein 4, Serologically defined breast cancer antigen NY-BR-20) (AP) discontinued?

Accepted Answer

The catalog number for CALML4, CT (CALML4, Calmodulin-like protein 4, Serologically defined breast cancer antigen NY-BR-20) (AP) discontinued is 033152-AP.

Question 2

What sizes are available for CALML4, CT (CALML4, Calmodulin-like protein 4, Serologically defined breast cancer antigen NY-BR-20) (AP) discontinued?

Accepted Answer

CALML4, CT (CALML4, Calmodulin-like protein 4, Serologically defined breast cancer antigen NY-BR-20) (AP) discontinued is available in the following size(s): 200 µL.

Question 3

Is CALML4, CT (CALML4, Calmodulin-like protein 4, Serologically defined breast cancer antigen NY-BR-20) (AP) discontinued in stock?

Accepted Answer

CALML4, CT (CALML4, Calmodulin-like protein 4, Serologically defined breast cancer antigen NY-BR-20) (AP) discontinued

Selected Variant

033152-AP

Size: 200 µL

Product Specifications

Clonality

Pab

Question 4

Can this product be used in multiplex assays?

Accepted Answer

Multiplex compatibility depends on the specific product and detection panel. Contact our technical support team with details of your multiplex system for guidance before ordering.

Question 5

What happens if this product doesn’t perform as expected in my experiment?

Accepted Answer

Send us the catalogue number, product name, lot number, and a summary of your results. Our technical support team will investigate and, where needed, involve the manufacturer. This is covered under our guarantee provided the product was used before its expiry date and stored correctly.

Question 6

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.